NeSST2: The Development of a Noninvasive Short Synacthen Test
NCT03514589
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Adrenal Suppression
Interventions
DRUG:
nasal Tetracosactide
DRUG:
IV tetracosactide
Sponsor
Sheffield Children's NHS Foundation Trust